Introduction

The use of all medicines may not only incur a risk of an adverse drug reaction (ADR) but also of a clinical incident such as an inappropriate reconstitution or administration error. These types of medication error risks can and should be minimised by “Purchasing for Safety” in the first instance.

All NHS pharmacy staff assume a duty of care when supplying a medicine. To reduce the number/frequency of incidents caused by medication errors it is essential that all risks are identified and assessed. Following risk identification and assessment action must be taken to minimise the possibility of a patient safety incident.

Effective procurement of the right medicine is an important tool in the risk reduction process. This includes Clinical Pharmacists not only assessing a product's clinical effectiveness and ADR potential but also its safety in use when responding to a request for a new medicine. Medicines should only be purchased if they are of a suitable quality, safe to use and fit for purpose. Moreover, it is essential that the procurement process assesses the capabilities of the supply chain to the hospital to ensure that products are genuine, have been correctly stored and are available when required.

 

Policy Details

Download: N/A
Compiled by: Sabah Ramji, Senior Pharmacy Operations Manager
Ratified by: Drug and Therapeutics Committee
Date Ratified: January 2024
Date Issued: February 2024
Review Date: January 2026
Target Audience: All Clinical staff who handle medicines
Contact name: Sabah Ramji, Senior Pharmacy Operations Manager

 

See also:

 

Protecting Your Online Privacy
Protecting Your Online Privacy

This Ashford and St Peter's website uses cookies to track visitor numbers. Find out more in our Cookies Policy and Privacy Policy. You can also read our Accessibility Statement and Privacy Notice for your information.